grow would certainli great
cerner result guidanc preliminari lt revenu growth updat satisfi
side debat bull point execut margin
bad revenu guidanc lt target appear
drastic differ old outlook absent low-margin work busi
bear counterargu level revenu growth come
pathway acceler question slower growth market
import thing view remain focu gener better total return
hit high end growth may tough visual without
contribut bottom end improv margin free cash flow gener
good enough us reiter buy rate increas po
better profit/cash flow progress target multipl
ev/ebitda await next growth updat himss investor brief
estim tweak lower like
lower ep ep
major underli assumpt chang core view
slightli lower revenu base model account announc divestitur
europ asset set close well build assum revenu
opex goe unannounc deal given desir pursu bolt-on
upcom event catalyst
import near-term event annual brief himss confer
march orlando one import data point updat
long-term revenu look like margin target importantli
though manag target on-going margin expans beyond initi
target addit new signific deal could also serv posit catalyst
final look new task order depart defens veteran
affair contract could drive increment comfort book perform
full definit iqmethod sm measur see page
bofa secur seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
largest stand-alone healthcar
compani sell wide rang softwar
servic hospit physician
product cerner millennium platform
serv base broader solut
offer also sell number addit
servic offer leverag clinic
infrastructur larg instal base
compani base kansa citi
buy rate base market leader
widest rang increment cross-sel
opportun within ever-grow custom
base compani also abl leverag
recent expens provid
increment cash flow appli
valuat overal market growth
slow vs post-american recoveri
reinvest act period see
continu share-gain becom
bifurc competit market
total revenu
book declin y/i due select book
revenu visibl remain next month
profession servic revenu grew
driven growth implement servic
off-set less revenu revwork termin
gross margin
driven higher parti servic feder busi lower margin
mix technolog resal
adj oper margin in-lin expect
expect activ
revenu came long term contract vs last year
progress dod go-liv slate late
provid busi benefit strong market tailwind
post-acut market behavior health bright spot deliv new
issu revenu guidanc
reduc level outsourc book continu select
contract
revenu headwind includ revwork addit ablevet
adj ep
expect slightli higher target due lower mix
outsourc revenu
framework growth beyond
feder part growth addit growth revenu
va ramp way annual revenu
expect level inorgan growth support strateg growth
shift lt servic book return y/i book growth
see compar book apples-to-appl comparison
conflict implement va contract sinc chang leadership
signific bipartisan support regardless leadership chang
interoper rule concern
vocal push aggress issu
well-posit meet implement timelin
make lot progress lumeri
over-attain ip mileston healtheint
long term growth rate va long term revenu opportun make
long term growth rate break detail growth
himss see upsid closer rang
va ramp year period grow reach
ah anomali client contractu agreement
go forward make decis
mileston expect around aw partnership
visibl partnership healtheint tip spear
migrat cloud
readi put revenue/book target
impact oper margin restructur cost
adj earn zero impact restructur cost
insight margin impact cloud invest
invest part expens
wont see benefit near-term go take time
chang interoper regulationsani risk legaci busi share repo
comfort net impact minim enabl bigger
swing busi strategi strateg growth
capextak number base build
slow
least per quarter repurchas
perspect growth ex-u
consist previou year opportun outsid us
new busi
price object base ev/ebitda
five-year averag reflect slower revenu growth opportun
downsid risk po market paus spend particularli driven
healthcar reform uncertainti increas competit pressur epic system
well newer cloud-bas entiti integr cost associ va
dod contract hamper margin upsid risk would come acceler
cross-sel opportun notabl around popul health revenu upsid va
contract roll-out increas leverag drive improv margin expans potenti
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa global research standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa global research
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
